Eradication of Chronic Myeloid Leukemia Stem Cells: A Novel Mathematical Model Predicts No Therapeutic Benefit of Adding G-CSF to Imatinib

• Jasmine Foo,

  Affiliation Computational Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Mark W. Drummond,

  Affiliation Section of Experimental Haematology, Medical Faculty, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Bayard Clarkson,

  Affiliation Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Tessa Holyoake,

  Affiliation Section of Experimental Haematology, Medical Faculty, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Franziska Michor

  * E-mail: michorf@mskcc.org

  Affiliation Computational Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯